agilon health, inc. (AGL)
NYSE: AGL · Real-Time Price · USD
96.78
+1.27 (1.33%)
At close: Aug 10, 2026, 4:00 PM EDT
98.01
+1.23 (1.27%)
Pre-market: Aug 11, 2026, 7:16 AM EDT

agilon health Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
5,9205,9336,0614,3162,3881,521
Revenue Growth
0.32%-2.11%40.41%80.74%56.96%24.88%
Gross Profit
13.84-160.024.8469.67111.3665.74
Operating Income
-309.33-463.24-292.13-232.13-105.38-372.24
Net Income
-251.22-391.35-260.15-262.6-106.55-406.49
Earnings Per Share
-14.27-24.50-15.25-12.00-5.50-25.75
EPS Growth
------

Revenue by Segment

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Medical Services
5,9115,9216,0484,3072,3851,518
Other Operating
9.1211.2412.829.013.333.17
Revenue (Total)
5,9205,9336,0614,3162,3881,521

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
185.63285.14399.97488.34877.21,040
Total Debt
30.2934.9934.932.3143.4848.4
Net Cash (Debt)
155.34250.15365.06456.04833.72991.64
Net Cash Growth
-46.81%-31.48%-19.95%-45.30%-15.93%2436.87%
Net Cash Per Share
9.2715.1122.2127.8851.0766.48

Cash Flow & CapEx

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-72.26-105.76-57.78-156.2-130.81-148.16
Capital Expenditures
-12.69-13.24-13.25-15.83-15.43-6.56
Free Cash Flow
-84.95-119.01-71.03-172.03-146.23-154.72
Free Cash Flow Growth
------

Margins

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
0.23%-2.70%0.08%1.61%4.66%4.32%
Operating Margin
-5.23%-7.81%-4.82%-5.38%-4.41%-24.47%
Pretax Margin
-4.23%-6.81%-4.11%-4.51%-3.80%-25.17%
Profit Margin
-4.24%-6.83%-4.13%-4.52%-3.87%-25.23%
FCF Margin
-1.43%-2.01%-1.17%-3.99%-6.12%-10.17%

Valuation

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Forward PE
-245.94245.94245.94--
PS Ratio
0.270.050.131.182.797.10